---
category: listing
circular_id: 2fbd7dab6a89954e
date: '2026-01-19'
description: 22,44,000 equity shares of DIPNA PHARMACHEM LIMITED issued on preferential
  basis pursuant to warrant conversion listed with effect from January 20, 2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={F85F4387-4AB6-436A-8F71-3DC8508101D8}&noticeno=20260119-16&dt=01/19/2026&icount=16&totcount=43&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of preferential allotment shares from warrant conversion
  for a single company with no broader market implications
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260119-16&attachedId=
processing:
  attempts: 1
  content_hash: 836d9d1b178f41c2
  processed_at: '2026-01-19T18:48:15.334758'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-19T12:26:54+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={F85F4387-4AB6-436A-8F71-3DC8508101D8}&noticeno=20260119-16&dt=01/19/2026&icount=16&totcount=43&flag=0
severity: low
source: bse
stocks:
- DIPNA
tags:
- listing
- equity-shares
- preferential-allotment
- warrant-conversion
- lock-in
title: Listing of New Securities of DIPNA PHARMACHEM LIMITED
---

## Summary

BSE has listed 22,44,000 new equity shares of DIPNA PHARMACHEM LIMITED (Scrip Code: 543594) with effect from January 20, 2026. These shares were issued to Non-Promoters on a preferential basis pursuant to conversion of warrants at an issue price of Rs. 13.05 per share. The shares are subject to a lock-in period until July 30, 2026.

## Key Points

- 22,44,000 equity shares of Rs. 10/- each issued at a premium of Rs. 3.05/-
- Issued to Non-Promoters on preferential basis through warrant conversion
- Date of allotment: November 29, 2025
- Issue price: Rs. 13.05 per share
- Distinctive numbers: 24045251 to 26289250
- ISIN: INE0MC401013
- Shares rank pari-passu with existing equity shares
- Trading permitted from January 20, 2026

## Regulatory Changes

No regulatory changes introduced by this circular.

## Compliance Requirements

- Trading members are informed to note the listing of these new securities
- Lock-in provisions must be observed for the allotted shares

## Important Dates

- **Date of Allotment:** November 29, 2025
- **Listing Date:** January 20, 2026
- **Lock-in Period Ends:** July 30, 2026

## Impact Assessment

This is a routine corporate action with minimal market impact. The listing of 22.44 lakh shares from warrant conversion represents a capital raising exercise for DIPNA PHARMACHEM LIMITED. The lock-in period until July 30, 2026 ensures these shares cannot be traded immediately, limiting short-term supply pressure. Impact is limited to shareholders and investors of this specific company.